Amphotericin B Penetrates into the Central Nervous System through Focal Disruption of the Blood-Brain Barrier in Experimental Hematogenous Candida Meningoencephalitis
暂无分享,去创建一个
B. Klaunberg | M. Lizak | D. Benjamin | T. Walsh | Vasilios J. Pyrgos | W. Hope | Jessica M Valdez | D. Kalasauskas | J. Bacher | A. Basevičius | R. Petraitiene | V. Petraitis | R. Petraitienė
[1] T. Walsh,et al. Invasive Candidiasis in Infants and Children: Recent Advances in Epidemiology, Diagnosis, and Treatment , 2019, Journal of fungi.
[2] F. Vilar,et al. Fluconazole levels in serum and cerebrospinal fluid according to daily dosage in patients with cryptococcosis and other fungal infections , 2017, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.
[3] H. Badali,et al. Antifungal susceptibility testing of Candida species isolated from the immunocompromised patients admitted to ten university hospitals in Iran: comparison of colonizing and infecting isolates , 2017, BMC Infectious Diseases.
[4] T. Walsh,et al. Drugs currently under investigation for the treatment of invasive candidiasis , 2017, Expert opinion on investigational drugs.
[5] J. Perfect. The antifungal pipeline: a reality check , 2017, Nature Reviews Drug Discovery.
[6] J. Perfect,et al. Experimental Models of Short Courses of Liposomal Amphotericin B for Induction Therapy for Cryptococcal Meningitis , 2017, Antimicrobial Agents and Chemotherapy.
[7] M. Finkelman,et al. (1→3)-β-d-Glucan in Cerebrospinal Fluid as a Biomarker for Candida and Aspergillus Infections of the Central Nervous System in Pediatric Patients. , 2016, Journal of the Pediatric Infectious Diseases Society.
[8] N. Frede,et al. Successful Granulocyte Colony-stimulating Factor Treatment of Relapsing Candida albicans Meningoencephalitis Caused by CARD9 Deficiency. , 2016, The Pediatric infectious disease journal.
[9] J. Sobel,et al. Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] Lloyd H. Michael,et al. The Guide for the Care and Use of Laboratory Animals. , 2016, ILAR journal.
[11] A. Schäffer,et al. Inherited CARD9 deficiency in otherwise healthy children and adults with Candida species-induced meningoencephalitis, colitis, or both. , 2015, The Journal of allergy and clinical immunology.
[12] A. Rosengart,et al. Mold infections of the central nervous system. , 2014, The New England journal of medicine.
[13] M. Walsh,et al. Neurodevelopmental outcome of extremely low birth weight infants with Candida infection. , 2013, The Journal of pediatrics.
[14] J. Perfect,et al. Pharmacokinetics and Pharmacodynamics of Fluconazole for Cryptococcal Meningoencephalitis: Implications for Antifungal Therapy and In Vitro Susceptibility Breakpoints , 2013, Antimicrobial Agents and Chemotherapy.
[15] Udo Albus,et al. Book Review: Guide for the Care and use of Laboratory Animals , 1998 .
[16] D. Stevens,et al. Experimental Central Nervous System Aspergillosis Therapy: Efficacy, Drug Levels and Localization, Immunohistopathology, and Toxicity , 2012, Antimicrobial Agents and Chemotherapy.
[17] H. Ibrahim,et al. In vitro antifungal susceptibilities of Candida isolates from patients with invasive candidiasis in Kuala Lumpur Hospital, Malaysia. , 2011, Journal of medical microbiology.
[18] T. Walsh,et al. Effects of Immunomodulatory and Organism-Associated Molecules on the Permeability of an In Vitro Blood-Brain Barrier Model to Amphotericin B and Fluconazole , 2009, Antimicrobial Agents and Chemotherapy.
[19] Maria R R Silva,et al. Susceptibility testing of Candida albicans isolated from oropharyngeal mucosa of HIV+ patients to fluconazole, amphotericin B and Caspofungin. killing kinetics of caspofungin and amphotericin B against fluconazole resistant and susceptible isolates , 2009, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology].
[20] Maria R R Silva,et al. Susceptibility testing of Candida albicans isolated from oropharyngeal mucosa of HIV+ patients to fluconazole, amphotericin B and Caspofungin: killing kinetics of caspofungin and amphotericin B against fluconazole resistant and susceptible isolates , 2009 .
[21] T. Walsh,et al. Cerebrospinal Fluid and Plasma (1→3)-β-d-Glucan as Surrogate Markers for Detection and Monitoring of Therapeutic Response in Experimental Hematogenous Candida Meningoencephalitis , 2008, Antimicrobial Agents and Chemotherapy.
[22] G. Drusano,et al. The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: implications for echinocandin therapy in neonates. , 2008, The Journal of infectious diseases.
[23] William Oh,et al. Neonatal Candidiasis Among Extremely Low Birth Weight Infants: Risk Factors, Mortality Rates, and Neurodevelopmental Outcomes at 18 to 22 Months , 2006, Pediatrics.
[24] T. Walsh,et al. Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques. , 2003, Pediatrics.
[25] J. McCullers,et al. Candidal meningitis in children with cancer. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[26] S. Piscitelli,et al. Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system. , 2000, The Journal of infectious diseases.
[27] T. Walsh,et al. Chronic silastic central venous catheterization for induction, maintenance and support of persistent granulocytopenia in rabbits. , 1988, Laboratory animal science.
[28] F. Balis,et al. Fluconazole penetration into cerebrospinal fluid: implications for treating fungal infections of the central nervous system. , 1988, The Journal of infectious diseases.
[29] M. Ghannoum,et al. Correlative relationship between proteinase production, adherence and pathogenicity of various strains of Candida albicans. , 1986, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.
[30] J. Church,et al. Case Report: Primary Candida Meningitis Chronic Granulomatous Disease , 1986 .
[31] J. Church,et al. Primary Candida meningitis and chronic granulomatous disease. , 1986, The American journal of the medical sciences.
[32] D. Alexander,et al. The National Institute of Child Health and Human Development , 1965, Nature.